Jubilant Biosys and Yale University collaboration to accelerate small molecule discovery program

SAN DIEGO - Feb. 18, 2021 - PRLog -- Areas of collaboration include medicinal chemistry, structural biology, in-vitro and in-vivo pharmacology among others.

Commenting on this collaboration, Marcel Velterop, President Jubilant Biosys said "Yale is one of the top-ranked academic institutions in the US and we at Jubilant Biosys are delighted to be able to support scientific endeavors of Investigators at Yale to pursue novel target ideas for unmet medical conditions. With our New Discovery Chemistry Site scheduled to commence operations in 2021, we will further add to our capability a new infrastructure to service our partners."

"Our CRO relationships are an integral component in our pursuit of helping Yale's scientific community transition their research towards commercialization, and we are pleased to have Jubilant Biosys join our entrepreneurial ecosystem," said Bill Wiesler, Director of New Ventures and the Blavatnik Fund for Innovation at Yale, Office of Cooperative Research.

About Jubilant Biosys Limited

Jubilant Biosys, a subsidiary of Jubilant Pharmova Limited, an integrated global pharmaceutical company, has a presence in Bengaluru and Noida in India. Jubilant Biosys offers contract research & development services for global pharmaceutical innovators. Biosys has demonstrated expertise in functional services such as Biology, DMPK (https://www.jubilantbiosys.com/services/dmpk/), Toxicology as well as Medicinal Chemistry and PR&D and GMP scale-up capabilities up to phase II.

For more info: www.jubilantbiosys.com

Media Contact:

Drishti Asthana
bd@jubilantbiosys.com

About the Yale Office of Cooperative Research

Since its founding in 1982, the Yale Office of Cooperative Research (OCR) has built a significant portfolio of inventions and patents and has grown into an engine of regional economic development. Its mission is to facilitate the translation of research from Yale's labs into products and services that benefit society. OCR is recognized as a leading force for catalyzing economic growth by identifying, counseling and nurturing early-stage technologies and guiding the transition into robust companies.

More information is available at https://ocr.yale.edu/

Media Contact:

Michelle McQueen
Yale University, Office of Cooperative Research
michelle.mcqueen@yale.edu
+1 917-370-6016